166 related articles for article (PubMed ID: 38816205)
1. Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3).
Ueno A; Onishi Y; Mise K; Yamaguchi S; Kanno A; Nojima I; Higuchi C; Uchida HA; Shikata K; Miyamoto S; Nakatsuka A; Eguchi J; Hida K; Katayama A; Watanabe M; Nakato T; Tone A; Teshigawara S; Matsuoka T; Kamei S; Murakami K; Shimizu I; Miyashita K; Ando S; Nunoue T; Wada J
BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38816205
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
[TBL] [Abstract][Full Text] [Related]
3. Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.
Gutta S; Grobe N; Kumbaji M; Osman H; Saklayen M; Li G; Elased KM
Am J Physiol Renal Physiol; 2018 Aug; 315(2):F263-F274. PubMed ID: 29561187
[TBL] [Abstract][Full Text] [Related]
4. Human recombinant ACE2 reduces the progression of diabetic nephropathy.
Oudit GY; Liu GC; Zhong J; Basu R; Chow FL; Zhou J; Loibner H; Janzek E; Schuster M; Penninger JM; Herzenberg AM; Kassiri Z; Scholey JW
Diabetes; 2010 Feb; 59(2):529-38. PubMed ID: 19934006
[TBL] [Abstract][Full Text] [Related]
5. Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study.
Shi C; Lu K; Xia H; Zhang P; Zhang B
Medicine (Baltimore); 2020 Jul; 99(31):e21492. PubMed ID: 32756181
[TBL] [Abstract][Full Text] [Related]
6. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
Bjornstad P; Wiromrat P; Johnson RJ; Sippl R; Cherney DZI; Wong R; Rewers MJ; Snell-Bergeon JK
Diabetes Care; 2019 Feb; 42(2):297-302. PubMed ID: 30482755
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition.
Liu CX; Hu Q; Wang Y; Zhang W; Ma ZY; Feng JB; Wang R; Wang XP; Dong B; Gao F; Zhang MX; Zhang Y
Mol Med; 2011; 17(1-2):59-69. PubMed ID: 20844835
[TBL] [Abstract][Full Text] [Related]
8. Imbalanced plasma ACE and ACE2 level in the uremic patients with cardiovascular diseases and its change during a single hemodialysis session.
Yang CW; Lu LC; Chang CC; Cho CC; Hsieh WY; Tsai CH; Lin YC; Lin CS
Ren Fail; 2017 Nov; 39(1):719-728. PubMed ID: 29157100
[TBL] [Abstract][Full Text] [Related]
9. Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis and coronary heart disease.
Zhou X; Zhang P; Liang T; Chen Y; Liu D; Yu H
Heart Vessels; 2020 Feb; 35(2):153-161. PubMed ID: 31359146
[TBL] [Abstract][Full Text] [Related]
10. Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population.
Younas H; Ijaz T; Choudhry N
PLoS One; 2022; 17(2):e0264038. PubMed ID: 35176079
[TBL] [Abstract][Full Text] [Related]
11. Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy.
Clotet-Freixas S; Soler MJ; Palau V; Anguiano L; Gimeno J; Konvalinka A; Pascual J; Riera M
Lab Invest; 2018 Sep; 98(9):1237-1249. PubMed ID: 29884907
[TBL] [Abstract][Full Text] [Related]
12. Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.
Bjornstad P; Pyle L; Cherney DZI; Johnson RJ; Sippl R; Wong R; Rewers M; Snell-Bergeon JK
Nephrol Dial Transplant; 2018 Jul; 33(7):1189-1196. PubMed ID: 28992280
[TBL] [Abstract][Full Text] [Related]
13. Serum cell-free DNA and progression of diabetic kidney disease: a prospective study.
Li X; Hu R; Luo T; Peng C; Gong L; Hu J; Yang S; Li Q
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32152147
[TBL] [Abstract][Full Text] [Related]
14. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
[TBL] [Abstract][Full Text] [Related]
15. Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.
Wysocki J; Goodling A; Burgaya M; Whitlock K; Ruzinski J; Batlle D; Afkarian M
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F487-F494. PubMed ID: 28468961
[TBL] [Abstract][Full Text] [Related]
16. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
[TBL] [Abstract][Full Text] [Related]
17. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
[TBL] [Abstract][Full Text] [Related]
18. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.
Furuhashi M; Moniwa N; Mita T; Fuseya T; Ishimura S; Ohno K; Shibata S; Tanaka M; Watanabe Y; Akasaka H; Ohnishi H; Yoshida H; Takizawa H; Saitoh S; Ura N; Shimamoto K; Miura T
Am J Hypertens; 2015 Jan; 28(1):15-21. PubMed ID: 24842388
[TBL] [Abstract][Full Text] [Related]
19. Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.
Xiao F; Hiremath S; Knoll G; Zimpelmann J; Srivaratharajah K; Jadhav D; Fergusson D; Kennedy CR; Burns KD
PLoS One; 2012; 7(5):e37649. PubMed ID: 22629438
[TBL] [Abstract][Full Text] [Related]
20. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
